Previous Page  5 / 5
Information
Show Menu
Previous Page 5 / 5
Page Background

Page 20

Notes:

allied

academies

September 06-07, 2018 | Edinburgh, Scotland

Pathology and Surgical Pathology

International Conference on

Journal of Pathology and Disease Biology | Volume 2

Ahmed A S Elhakeem

Dalia A Elsers, Rabab M H and Elgaroryand Sana S Kroosh

Al-Azhar University, Egypt

Effect of hypoxic microenvironment on expression of stem cell marker (nestin) in

astrocytic tumors

Introduction:

Gliomas account for 40% of the primary

central nervous system tumors in western countries, and

for about one-third (37.3%) in Egypt. Identification of

the cellular origin of gliomas presents an opportunity for

improving the treatment strategies. It has been postulated

that astrocytomas may be originated from neural stem cells.

Hypoxia-inducible factor-1a (HIF-1a) is considered one of

the key hypoxia regulatory factors. Hypoxia may be a critical

component of a stem cell niche and contributes to the tumor

initiation and maintenance of cancer stem cells (CSCs). In

the present study, we hypothesized that the expression of

stem cell marker (nestin) and hypoxia marker (HIF-1a) may

be upregulated with increasing grades of astrocytomas. In

addition, there is a correlation between hypoxia and stem

cell marker in all grades of astrocytomas in both tumor cells

(TRCs) and vascular endothelial cells (VECs). To explore our

hypothesis, this study was organized into specific aims: (a)

analysis of the immunohistochemical expression of nestin

and HIF-1a in different grades of astrocytomas and (b)

analysis of the correlation between nestin and HIF-1a in

different grades of astrocytomas.

Materials and methods:

Paraffin-embedded sections of 43

specimens of astrocytic tumors (nine pilocytic astrocytoma,

13 diffuse astrocytomas, seven anaplastic astrocytomas, and

14 glioblastoma multiforme) and six normal brain tissue (as

a control) were stained with nestin and HIF-1a using standard

immunohistochemical approaches. The immunoreactivity

for nestin and HIF-1a in both TRCs and VECs was evaluated.

Correlation between nestin and HIF-1a expression was also

studied.

Results:

The expression of nestin in TRCs was present in

88.4% of patients. As compared with normal brain tissue,

there was statistically significant (P < 0.01) gradual increase

in the mean of nestin immunoreactivity score with increasing

grade of the studied astrocytomas (I–IV) (0.0 ± 0.0, 1.7 ±

1.8, 2.5 ± 1.6, 5.7 ±3.2, and 7.8± 2.5, respectively). The

expression of HIF-1a was seen in 65.1% of studied patients.

The immunoreactivity score of HIF-1a showed significant

(P < 0.001) difference between low-grade astrocytomas

(pilocytic astrocytoma and diffuse astrocytomas) and

high-grade astrocytomas (anaplastic astrocytomas and

glioblastoma multiforme). There was statistically significant

positive correlation between expression of nestin and HIF-1a

in both TRCs and VECs (r =0.71 and 0.47, respectively, and P

< 0.001 for both).

Conclusion:

Restricted oxygen conditions increase the CSC

fraction. Determining the cross-talk between hypoxia and

CSCs will enhance the understanding of tumorigenesis and

may provide new therapeutic strategy. Intense expression

of nestin in high-grade astrocytomas may be helpful in their

diagnosis especially in small biopsy.

Speaker Biography

Ahmed A S Elhakeem is working as a lecturer at the Department of Pathology

of Assiut University in Egypt. His professional affiliation entails being a member

of the International Society of Neuropathology, Egyptian society of Pathology

and Egyptian society of progenitor cell research. He excels in the subspecialty

of Neuropathology with over 10 years of experience in the diagnosis of

brain and spinal lesions. His research interest also covers cancer stem cells.

e:

ahmed.elhakeem2011@yahoo.com